GSK (GSK) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.45
- Estimate
- $1.33
- Surprise
- +9.5%
- Score at report (before → after)
- 5.5 → 5.7/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
GSK (GSK) beat the $1.33 estimate with adjusted EPS of $1.45 — a clear 9.5% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.5/10) to Hold at 5.7/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates GSK Hold at 5.7/10.
4 of the last 4 quarters beat the estimate; this quarter's +9.5% surprise compares with a +9.1% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Thin upside margin: 8.0%
- Leverage penalty (D/E 1.1): -0.5
- Weak growth
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $48.74
- Price target
- $52.65
- Stop
- $46.32
- Upside to target
- +8.0%
- Reward-to-risk
- 1.3:1
The stock trades at 17.0× trailing but 9.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
GSK at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - General
- Market cap
- $97.65B
- P/E (fwd)
- 9.8
- P/E (ttm)
- 17.0
- 52-week range
- $45.50–$61.70
- Off 52-week high
- 21.0%
- RSI (14)
- 60
- Volume vs avg
- 1.35×
- Score today
- 5.7/10